Literature DB >> 8093809

Mortality risks in gay men with human immunodeficiency virus infection and cognitive impairment.

R Mayeux1, Y Stern, M X Tang, G Todak, K Marder, M Sano, M Richards, Z Stein, A A Ehrhardt, J M Gorman.   

Abstract

We obtained data from 111 gay men who entered a longitudinal study of the natural history of human immunodeficiency virus (HIV) without clinical evidence of acquired immunodeficiency syndrome (AIDS), and examined them regularly over a 36-month period. Using a Cox proportional-hazard regression model to compare cumulative risk of mortality in subjects with and without cognitive impairment and several putative risk factors present at baseline, we found that the mortality risk ratio (RR) associated with poor neuropsychologic test performance was significantly increased (RR = 2.9; 95% confidence interval [CI], 1.1 to 7.8), and increased further (RR = 4.1; 95% CI, 1.3 to 12.5) when adjusted for other factors associated with mortality (a history of a disturbance in movement or gait, CD4-lymphocyte and red blood-cell counts, and age). A significant increase in symptoms related to cognitive impairment and gait, a decline in neuropsychologic test performance, and declines in CD4-lymphocyte and red-cell counts occurred over the study period. A second model was constructed to adjust for changes in CD4-lymphocyte and red-cell counts, age, medical stage, and motor symptoms over the study period, but the mortality RR for poor neuropsychologic test performance at baseline changed very little (RR = 4.7; 95% CI, 1.5 to 14.9). We conclude that the presence of cognitive impairment, manifest by poor neuropsychologic test performance in both asymptomatic and symptomatic gay men with HIV infection, is associated with a significantly increased risk of death. This effect progresses in parallel with the immunologic and systemic effects of HIV.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8093809     DOI: 10.1212/wnl.43.1_part_1.176

Source DB:  PubMed          Journal:  Neurology        ISSN: 0028-3878            Impact factor:   9.910


  21 in total

Review 1.  Human immunodeficiency virus-associated dementia: an evolving disease.

Authors:  Justin C McArthur; Norman Haughey; Suzanne Gartner; Kathy Conant; Carlos Pardo; Avi Nath; Ned Sacktor
Journal:  J Neurovirol       Date:  2003-04       Impact factor: 2.643

Review 2.  Neuropsychiatric aspects of HIV infection.

Authors:  I P Everall
Journal:  J Neurol Neurosurg Psychiatry       Date:  1995-04       Impact factor: 10.154

3.  Altered Monoamine and Acylcarnitine Metabolites in HIV-Positive and HIV-Negative Subjects With Depression.

Authors:  Edana Cassol; Vikas Misra; Susan Morgello; Gregory D Kirk; Shruti H Mehta; Dana Gabuzda
Journal:  J Acquir Immune Defic Syndr       Date:  2015-05-01       Impact factor: 3.731

4.  Neurocognitive impairment associated with predominantly early stage HIV infection in Abuja, Nigeria.

Authors:  Christopher Akolo; Walter Royal; Mariana Cherner; Kanayo Okwuasaba; Lindsay Eyzaguirre; Ruxton Adebiyi; Anya Umlauf; Terence Hendrix; Joyce Johnson; Alashl'e Abimiku; William A Blattner
Journal:  J Neurovirol       Date:  2014-06-14       Impact factor: 2.643

5.  HIV-associated neurocognitive disorders persist in the era of potent antiretroviral therapy: CHARTER Study.

Authors:  R K Heaton; D B Clifford; D R Franklin; S P Woods; C Ake; F Vaida; R J Ellis; S L Letendre; T D Marcotte; J H Atkinson; M Rivera-Mindt; O R Vigil; M J Taylor; A C Collier; C M Marra; B B Gelman; J C McArthur; S Morgello; D M Simpson; J A McCutchan; I Abramson; A Gamst; C Fennema-Notestine; T L Jernigan; J Wong; I Grant
Journal:  Neurology       Date:  2010-12-07       Impact factor: 9.910

6.  Impaired Neurocognitive Performance and Mortality in HIV: Assessing the Prognostic Value of the HIV-Dementia Scale.

Authors:  Nikhil Banerjee; Roger C McIntosh; Gail Ironson
Journal:  AIDS Behav       Date:  2019-12

7.  Characterization and sociocultural predictors of neuropsychological test performance in HIV+ Hispanic individuals.

Authors:  Monica Rivera Mindt; Desiree Byrd; Elizabeth L Ryan; Reuben Robbins; Jennifer Monzones; Alyssa Arentoft; Kaori Kubo Germano; Debra E Henniger; Susan Morgello
Journal:  Cultur Divers Ethnic Minor Psychol       Date:  2008-10

8.  Neurobehavioral effects of human immunodeficiency virus infection among former plasma donors in rural China.

Authors:  Robert K Heaton; Lucette A Cysique; Hua Jin; Chuan Shi; Xin Yu; Scott Letendre; Donald R Franklin; Christopher Ake; Ofilio Vigil; J Hampton Atkinson; Thomas D Marcotte; Igor Grant; Zunyou Wu
Journal:  J Neurovirol       Date:  2008-11       Impact factor: 2.643

Review 9.  Update on HIV dementia and HIV-associated neurocognitive disorders.

Authors:  Bruce J Brew; Phillip Chan
Journal:  Curr Neurol Neurosci Rep       Date:  2014-08       Impact factor: 5.081

10.  Central nervous system penetration effectiveness of antiretroviral drugs and neuropsychological impairment in the Ontario HIV Treatment Network Cohort Study.

Authors:  Adriana Carvalhal; M John Gill; Scott L Letendre; Anita Rachlis; Tsegaye Bekele; Janet Raboud; Ann Burchell; Sean B Rourke
Journal:  J Neurovirol       Date:  2015-11-16       Impact factor: 2.643

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.